Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
60 Degrees Pharmaceuticals, Inc. ( (SXTP) ) has issued an update.
On March 20, 2026, 60 Degrees Pharmaceuticals, Inc. reported that it had miscalculated the number of shares of common stock beneficially owned by a company affiliate in a prospectus supplement dated March 13, 2026. The affiliate’s holdings were previously disclosed as 21,490 shares but have been corrected to 23,367 shares, reflecting a revised total of 16,781 shares after a 1-for-4 reverse stock split instead of the earlier reported 15,905.
The company traced the discrepancy to an erroneous total share amount in a Form 4 filed on September 15, 2025, which was carried forward into a subsequent Form 4 on December 16, 2025, and then into the prospectus supplement. By filing a current report to amend this ownership disclosure, 60 Degrees Pharmaceuticals indicates that the error is limited to these figures and that no other information in the prospectus supplement has been affected, clarifying the record for investors and regulators.
The most recent analyst rating on (SXTP) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on 60 Degrees Pharmaceuticals, Inc. stock, see the SXTP Stock Forecast page.
Spark’s Take on SXTP Stock
According to Spark, TipRanks’ AI Analyst, SXTP is a Neutral.
The score is held down primarily by very weak fundamentals (outsized losses and ongoing cash burn) and a significant Nasdaq delisting risk. Technical signals are comparatively supportive, but valuation is constrained by continued unprofitability and no dividend support.
To see Spark’s full report on SXTP stock, click here.
More about 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. operates in the biopharmaceutical sector, focusing on the development and commercialization of therapies for infectious diseases. The company targets specialized medical needs where existing treatment options are limited, aiming to serve both domestic and global healthcare markets.
Average Trading Volume: 4,587,162
Technical Sentiment Signal: Sell
Current Market Cap: $4.77M
See more insights into SXTP stock on TipRanks’ Stock Analysis page.